{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-045302","form_type":"8-K","ticker":"IVVD","cik":"0001832038","company_name":"Invivyd, Inc.","filed_at":"2025-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.156211+00:00","generated_at":"2026-05-24T05:12:49.424083+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Invivyd appoints Ajay Royan (Mithril Capital) to Board of Directors","bullets":["Royan appointed effective March 22, 2025; term expires at 2025 annual meeting.","Royan is founder of Mithril Capital, a significant long-term holder of IVVD stock.","He will receive $40,000 annual cash retainer and option for 100,000 shares vesting over 3 years.","Royan led the 2022 shareholder action that focused Invivyd on COVID-19 monoclonal antibodies.","Company plans to advance into higher-value medicines for vulnerable populations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-045302","json":"https://secwatch.observer/filing/0000950170-25-045302.json","markdown":"https://secwatch.observer/filing/0000950170-25-045302.md","text":"https://secwatch.observer/filing/0000950170-25-045302.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832038/000095017025045302/0000950170-25-045302-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832038/000095017025045302/ivvd-20250322.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T05:12:49.424083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad816b3f47","claim":"Ajay Royan was appointed as director at Invivyd, Inc..","evidence_excerpt":"On March 22, 2025, the Board of Directors (the “Board”) of Invivyd, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Ajay Royan as a director, effective immediately, with his term expiring at the Company’s 2025 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832038/000095017025045302/0000950170-25-045302-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}